- Second transaction under the Innvierte Deep Start framework, an instrument created by CDTI Innvierte and the EIF to mobilize public-private investment in high-impact deep-tech projects.
- Asabys Innvierte Tech Transfer is managed by Asabys Partners, and with a target size of up to €120 million, the fund will foster the creation and development of innovative companies in life sciences and health, with a focus on biotechnology and medical technologies.
- This transaction is part of the measures under Spain's National Deep Tech Strategy 2026–2030 and also contributes to the EIF's strategic priority of driving technological innovation in the EU.
The Spanish Ministry of Science, Innovation and Universities (MICIU), through the Centre for the Development of Industrial Technology (CDTI), and the European Investment Fund (EIF) have formalised a joint investment of €74.7 million in the Asabys Innvierte Tech Transfer FCRE fund, managed by Asabys Partners. This investment is made through the Innvierte Deep Start financial instrument.
The Asabys Innvierte Tech Transfer FCRE fund, specialised in biotechnology and medical technologies, will invest in the creation and development of innovative companies in the field of deep-tech applied to health, drawing on Spanish scientific excellence, with a particular focus on technology transfer from universities, hospitals and research centres. The fund will invest at very early stages, including both the creation of academic spin-offs and the incubation of projects requiring pre-seed financing to reach proof of concept with an industrial focus. The aim is to foster companies that maximise the use of deep-tech technologies such as artificial intelligence, supercomputing, synthetic biology and new materials, as well as new therapeutic modalities.
This transaction is the second investment made through the Innvierte Deep Start financial instrument, integrated within the scope of Spain's National Deep Tech Strategy 2026–2030. Innvierte Deep Start has a total endowment of €353 million, of which €300 million are contributed by the MICIU through CDTI's SICC Innvierte and €53 million by the EIF. The aim of Innvierte Deep Start is to reinforce the MICIU's strategy to boost Spanish innovation at early stages (TRL 2–4), strengthening the value chain and the transfer from universities and R&D centres through to market scale-up and internationalisation, in order to convert Spanish research into high added-value solutions.
With the investment in Asabys Innvierte Tech Transfer, the Ministry of Science, Innovation and Universities, CDTI Innvierte and the EIF are reinforcing their commitment to innovation and technology transfer, consolidating Spanish scientific research access to the financing needed to develop real solutions that improve citizens' lives and strengthen the competitiveness of the Spanish economy. The Innvierte Deep Start instrument thus contributes to positioning Spain as an international reference destination for funds specialised in deep-tech.
In this joint indirect co-investment scheme, CDTI and the EIF act as Limited Partners, endorsing the work of professional fund managers and channelling resources towards funds with a solid track record in technological, financial and sustainability fields. CDTI Innvierte's collaboration with the EIF under the Innvierte Deep Start framework also increases the visibility of Spanish startups and helps attract international co-investments.
Background information
Innvierte is an initiative aimed at promoting business innovation by supporting venture capital investment in technology-based or innovative companies. This programme is implemented through the closed-ended collective investment company Innvierte Economía Sostenible SICC S.M.E., S.A., self-managed and subject to the supervision of the National Securities Market Commission (CNMV), of which CDTI Innovación is the sole shareholder. To date, CDTI Innovación has committed, through Innvierte, €3,478.5 million in 61 investment vehicles and, through its co-investment line, has directly committed €866.1 million in 197 companies. Innvierte is part of the Spanish Strategy for Science, Technology and Innovation 2021–2027, approved by Agreement of the Council of Ministers in September 2020. This Strategy contains the objectives, reforms and measures to be adopted across the entire R&D&I sphere with the aim of driving its growth and impact, and is one of the pillars on which the Government's R&D&I policy for the coming years is based.
The Centre for the Development of Industrial Technology, CDTI E.P.E., is the innovation agency of the Ministry of Science, Innovation and Universities, whose objective is to promote technological innovation in the business sector. CDTI's mission is to ensure that the Spanish business fabric generates and transforms scientific and technical knowledge into globally competitive, sustainable and inclusive growth. In 2025, within the framework of the Strategic Plan 2024–2027, CDTI provided more than €2 billion in support to Spanish companies and startups.
The European Investment Bank (EIB) Group is the financing arm of the European Union, owned by the 27 Member States, and one of the largest multilateral development banks in the world. In 2025, the EIB Group signed €100 billion in new financing and advisory services for over 870 high-impact projects under eight core priorities that support EU policy objectives: climate action and the environment, digitalisation and technological innovation, security and defence, territorial cohesion, agriculture and the bioeconomy, social infrastructure, strong global partnerships and the savings and investments union. Beyond long-term loans for large infrastructure, the EIB Group crowds in private investment for high-risk innovative projects and businesses, with a growing role in Europe’s markets for venture debt, venture capital, guarantees and securitisations. The EIB Group completed financing and investment operations in Spain totaling around €11 billion last year, which came alongside an additional €2.9 billion under the Regional Resilience Fund (NextGenerationEU loans).
The European Investment Fund (EIF) is the subsidiary of the EIB Group specialised in providing guarantees and equity to improve access to finance for small and medium-sized businesses and startups across Europe. Acting as an anchor investor, through its extensive network of partnering banks and investment funds, the EIF mobilises private investment and nurtures the ecosystem of venture capital funds to support innovative European entrepreneurs. In 2023, the EIF together with six Member States (France, Germany, Italy, Spain, Belgium and the Netherlands) launched the European Tech Champions Initiative, a fund-of-funds to scale up innovative startups. To date, this initiative has already enabled the creation of 15 European venture capital mega-funds and scaled up 43 companies, including 11 unicorns (with more than €1 billion in capital).
Photos of the EIB Group's representatives and headquarters, logo files and video B-roll for media use are available here.
Asabys Partners is a venture capital firm headquartered in Barcelona, specialising in health innovation and life sciences, including biotechnology, medical technologies and digital health. Founded in 2018 by Josep Ll. Sanfeliu and Clara Campàs, the firm is backed by Alantra and has Banc Sabadell as its anchor investor. Asabys aims to support highly innovative and transformative technologies that address unmet medical needs. The firm manages more than €400 million in assets and has 23 portfolio companies. Asabys positions itself not only as an investor but also as an active and collaborative partner of its portfolio companies, with the objective of translating disruptive science into tangible outcomes for patients.